The NSW-RPRN consists of three pillars, bringing together development projects and key support capabilities to progress potential RNA therapeutics through pre-clinical trials.
NSW-RPRN Member Organisations
The NSW-RPRN includes several universities and medical research institutions and has built relationships with a number of support organizations located in NSW and the ACT that provide critical infrastructure and expertise for the development of RNA-based therapeutics:
- UNSW
- UTS
- Macquarie University
- University of Sydney
- ANU
- Children’s Medical Research Institute
- Kirby Institute
- Westmead Institute of Medical Research
- Woolcock Institute of Medical Research
- Children’s Cancer Institute
- Royal Prince Alfred Hospital
- Ramaciotti Centre for Genomics
- UNSW Recombinant Products Facility
- Centenary Institute
- Australian Proteome Analysis Facility
- The ANU Centre for Therapeutic Discovery
- Cell & Molecular Therapies
- Microbial Genomics Reference Laboratory
- Sydney Infectious Diseases Institute
Management Committee
Pall Thordarson – Coordinator, UNSW Sydney
Scott Cohen – Children’s Medical Research Institute, Westmead
Daniela Traini – Woolcock Institute
Richard Payne – University of Sydney
Christopher Marquis – UNSW Sydney
Anthony Kelleher – Kirby Institute
Maria Kavallaris – Children’s Cancer Institute
External Expert Advisory Committee
Scott McNeil – University of Basel
Julie Suman – Next Breath
Archa Fox – University of Western Australia
Gary Philips – Pharmaxis
Phil Kearney -- Merck
John Skerritt – TGA Australia (observer)
Management and Administration
UNSW is the lead institution and is the base for management and governance of the NSW-RPRN including activities such as reporting and outreach.
Key Contacts: Joshua Peterson, Catherine McDonald, Marjorie Fox-Owens